Inventor · disambiguated record
Kevin W. Gelston
Also filed as: GELSTON KEVIN · GELSTON KEVIN W
6 granted patents·7 pending applications·63 citations·filing 2016–2024
84Inventor score
Top patents by PatentIndex Score
13 records- 0194US12042614B2Transdermal drug delivery devices and methodsMORNINGSIDE VENTURE INVESTMENTS LTD·Filed 2022·Granted Jul 23, 2024·13 cites·23 claims
- 0294US10232156B2Drug delivery methods and systemsCHRONO THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2019·27 cites·15 claims
- 0392US12011560B2Drug delivery methods and systemsMORNINGSIDE VENTURE INVESTMENTS LTD·Filed 2022·Granted Jun 18, 2024·2 cites·1 claims
- 0491US10213586B2Drug delivery methods and systemsCHRONO THERAPEUTICS INC·Filed 2016·Granted Feb 26, 2019·12 cites·31 claims
- 0586US11285306B2Transdermal drug delivery devices and methodsMORNINGSIDE VENTURE INVESTMENTS LTD·Filed 2018·Granted Mar 29, 2022·6 cites·17 claims
- 0682US11400266B2Drug delivery methods and systemsMORNINGSIDE VENTURE INVESTMENTS LTD·Filed 2019·Granted Aug 2, 2022·3 cites·59 claims
- 0782US2024424270A1Drug delivery methods and systemsMORNINGSIDE VENTURE INVESTMENTS LTD·Filed 2024·Application pending·0 cites
- 0858US2023413812A1Sanitizing compositions containing ionic liquidCAGE BIO INC·Filed 2021·Application pending·0 cites
- 0952US2023329988A1Sanitizing compositions containing ionic liquidCAGE BIO INC·Filed 2021·Application pending·0 cites
- 1052US2023087487A1Topical delivery of rna interference agents using ionic liquidCAGE BIO INC·Filed 2020·Application pending·0 cites
- 1152US2023372273A1Ionic liquid compositions for skin diseases and conditionsCAGE BIO INC·Filed 2021·Application pending·0 cites
- 1248US2022401447A1Topical delivery of tofacitinib using ionic liquidCAGE BIO INC·Filed 2020·Application pending·0 cites
- 1346US2019374482A1Transdermal drug delivery devices and methodsCHRONO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin W. Gelston files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →